These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 24942977

  • 1. A determination of the current causes of hyperkalaemia and whether they have changed over the past 25 years.
    Muschart X, Boulouffe C, Jamart J, Nougon G, Gérard V, de Cannière L, Vanpee D.
    Acta Clin Belg; 2014 Aug; 69(4):280-4. PubMed ID: 24942977
    [Abstract] [Full Text] [Related]

  • 2. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
    Raml A, Schmekal B, Grafinger P, Biesenbach G.
    Dtsch Med Wochenschr; 2001 Nov 23; 126(47):1327-30. PubMed ID: 11719857
    [Abstract] [Full Text] [Related]

  • 3. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
    Gluhovschi G, Mateş A, Gluhovschi C, Golea O, Gădălean F, Somai M, Ene I, Petrica L, Velciov S.
    Rom J Intern Med; 2014 Nov 23; 52(1):30-8. PubMed ID: 25000676
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial.
    Pitt B, Anker SD, Bushinsky DA, Kitzman DW, Zannad F, Huang IZ, PEARL-HF Investigators.
    Eur Heart J; 2011 Apr 23; 32(7):820-8. PubMed ID: 21208974
    [Abstract] [Full Text] [Related]

  • 5. Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.
    Indermitte J, Burkolter S, Drewe J, Krähenbühl S, Hersberger KE.
    Drug Saf; 2007 Apr 23; 30(1):71-80. PubMed ID: 17194172
    [Abstract] [Full Text] [Related]

  • 6. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone.
    Cruz CS, Cruz AA, Marcílio de Souza CA.
    Nephrol Dial Transplant; 2003 Sep 23; 18(9):1814-9. PubMed ID: 12937229
    [Abstract] [Full Text] [Related]

  • 7. [Hyperkalemias].
    Radó J, Haris A.
    Orv Hetil; 1999 Nov 21; 140(47):2611-8. PubMed ID: 10613044
    [Abstract] [Full Text] [Related]

  • 8. Spironolactone use and renal toxicity: population based longitudinal analysis.
    Wei L, Struthers AD, Fahey T, Watson AD, Macdonald TM.
    BMJ; 2010 May 18; 340():c1768. PubMed ID: 20483947
    [Abstract] [Full Text] [Related]

  • 9. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr 18; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

  • 10. Long-term mortality and trajectory of potassium measurements following an episode of acute severe hyperkalaemia.
    Gorriz JL, D'Marco L, Pastor-González A, Molina P, Gonzalez-Rico M, Puchades MJ, Sanchis I, Escudero V, Estañ N, de la Espriella R, Nuñez E, Pallardó L, Núñez J.
    Nephrol Dial Transplant; 2022 Feb 25; 37(3):522-530. PubMed ID: 33508124
    [Abstract] [Full Text] [Related]

  • 11. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade.
    Khosla N, Kalaitzidis R, Bakris GL.
    Am J Nephrol; 2009 Feb 25; 30(5):418-24. PubMed ID: 19738369
    [Abstract] [Full Text] [Related]

  • 12. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on serum potassium levels and renal function in ambulatory outpatients: risk factors analysis.
    Maddirala S, Khan A, Vincent A, Lau K.
    Am J Med Sci; 2008 Oct 25; 336(4):330-5. PubMed ID: 18854676
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
    Surabenjawong U, Thunpiphat N, Chatsiricharoenkul S, Monsomboon A.
    J Med Assoc Thai; 2013 Aug 25; 96(8):905-10. PubMed ID: 23991595
    [Abstract] [Full Text] [Related]

  • 14. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP, Aaronson KD, Koelling TM.
    Am Heart J; 2004 Dec 25; 148(6):971-8. PubMed ID: 15632880
    [Abstract] [Full Text] [Related]

  • 15. Impact of worsening renal function related to medication in heart failure.
    Brunner-La Rocca HP, Knackstedt C, Eurlings L, Rolny V, Krause F, Pfisterer ME, Tobler D, Rickenbacher P, Maeder MT, TIME‐CHF investigators.
    Eur J Heart Fail; 2015 Feb 25; 17(2):159-68. PubMed ID: 25808849
    [Abstract] [Full Text] [Related]

  • 16. [A patient with severe hyperkalaemia -- an emergency after RALES].
    Nürnberger J, Daul A, Philipp T.
    Dtsch Med Wochenschr; 2005 Sep 09; 130(36):2008-11. PubMed ID: 16143930
    [Abstract] [Full Text] [Related]

  • 17. Hyperkalaemia in the age of aldosterone antagonism.
    Chapagain A, Ashman N.
    QJM; 2012 Nov 09; 105(11):1049-57. PubMed ID: 22723454
    [Abstract] [Full Text] [Related]

  • 18. Hyperkalaemia and haemodialysis patients: eletrocardiographic changes.
    Cobo Sánchez JL, Alconero Camarero AR, Casaus Pérez M, Maza Sota MA, Villa Llamazares C, Hiquera Roldán C, Menezo Viadero R, Alonso Nates R.
    J Ren Care; 2007 Nov 09; 33(3):124-9. PubMed ID: 19160884
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the concurrent use of potassium-influencing drugs as risk factors for the development of hyperkalemia.
    Kuijvenhoven MA, Haak EA, Gombert-Handoko KB, Crul M.
    Int J Clin Pharm; 2013 Dec 09; 35(6):1099-104. PubMed ID: 23974985
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and factors associated with false hyperkalaemia in Asians in primary care: a cross-sectional study (the Unlysed Hyperkalaemia- the Unseen Burden (UHUB) study).
    Boo AYY, Koh YLE, Hu PL, Tan NC.
    BMJ Open; 2020 Sep 22; 10(9):e033755. PubMed ID: 32963061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.